Medline Inc.
MDLN
$34.05
-$0.64-1.85%
NASDAQ
| 06/27/2026 | 03/28/2026 | 12/31/2025 | 09/27/2025 | 06/28/2025 | |
|---|---|---|---|---|---|
| Revenue | 12.12% | 12.07% | 11.39% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.12% | 12.07% | 11.39% | -- | -- |
| Cost of Revenue | 14.09% | 14.27% | 12.62% | -- | -- |
| Gross Profit | 6.92% | 6.22% | 8.11% | -- | -- |
| SG&A Expenses | 13.33% | 11.34% | 10.96% | -- | -- |
| Depreciation & Amortization | 0.71% | 1.73% | 2.70% | -- | -- |
| Other Operating Expenses | 568.33% | 39.58% | 55.84% | -- | -- |
| Total Operating Expenses | 14.93% | 13.44% | 12.11% | -- | -- |
| Operating Income | -18.45% | -3.18% | 3.48% | -- | -- |
| Income Before Tax | -19.63% | -6.25% | 0.28% | -- | -- |
| Income Tax Expenses | 173.61% | 135.19% | 97.83% | -- | -- |
| Earnings from Continuing Operations | -30.60% | -12.47% | -3.46% | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -45.35% | -21.27% | -3.30% | -- | -- |
| EBIT | -18.45% | -3.18% | 3.48% | -- | -- |
| EBITDA | -11.98% | -1.15% | 3.48% | -- | -- |
| EPS Basic | 823.65% | 1,204.24% | 1,588.48% | -- | -- |
| Normalized Basic EPS | 1,587.61% | 2,882.73% | 2,085.45% | -- | -- |
| EPS Diluted | 811.54% | 1,185.15% | 1,588.48% | -- | -- |
| Normalized Diluted EPS | 1,583.33% | 2,877.27% | 2,085.45% | -- | -- |
| Average Basic Shares Outstanding | -42.90% | 109.61% | 104.91% | -- | -- |
| Average Diluted Shares Outstanding | -61.90% | 4.82% | 204.91% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.77% | -0.55% | -0.65% | -- | -- |